A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
Inclusion Criteria:
For enrollment into the HUMIRA treatment group; adult patients with moderately to severely active UC who has been prescribed HUMIRA therapy according to routine clinical practice and meets one of the following:
For enrollment into the IMM treatment group; adult patients with moderately to severely active UC who has been prescribed IMM therapy, is currently taking IMM therapy, and has received at least 12 consecutive weeks of IMM therapy
Patients capable of and willing to grant authorization for use/disclosure of data being collected and provided to AbbVie prior to any registry-related data being collected, and to comply with the requirements of the Registry protocol
Exclusion Criteria:
Tucson, Arizona 85719-1478, United States
Yorba Linda, California 92886, United States
Wheat Ridge, Colorado 80033-2896, United States
Washington D.C., District of Columbia 20007, United States
Brandon, Florida 33510-3107, United States
Chicago, Illinois 60611-2927, United States
Urbana, Illinois 61801, United States
Chevy Chase, Maryland 20815, United States
Ann Arbor, Michigan 48109, United States
Lake Success, New York 11042, United States
New York, New York 10024, United States
Charlotte, North Carolina 28207, United States
Winston-Salem, North Carolina 27157, United States
Hershey, Pennsylvania 17033, United States
Columbia, South Carolina 29203-8902, United States
Innsbruck, 6020, Austria
Edmonton, Alberta T6G 2X8, Canada
Vancouver, British Columbia V5Z 3N9, Canada
Vancouver, British Columbia V6Z 2K5, Canada
London, Ontario N6A 5A5, Canada
Montreal, Quebec H1T 2M4, Canada
Osijek, County of Osijek-Baranja 31000, Croatia
Copenhagen Ø, Capital Region 2100, Denmark
St-Priest-en-Jarez, Pays de la Loire Region 42270, France
Heidelberg, Baden-Wurttemberg 69121, Germany
Herne, North Rhine-Westphalia 44623, Germany
Minden, North Rhine-Westphalia 32423, Germany
Ludwigshafen am Rhein, Rhineland-Palatinate 67067, Germany
Leipzig, Saxony 04105, Germany
Kiel, Schleswig-Holstein 24146, Germany
Berlin-Zehlendorf, 14163, Germany
Amaroussio, Attica 15123, Greece
Athens, 10676, Greece
Athens, 10676, Greece
Elm Park, Dublin D04 T6F4, Ireland
Kiriat Bialik, 27000, Israel
Lower Galilee, 15208, Israel
Bologna, Emilia-Romagna 40138, Italy
San Giovanni Rotondo, Foggia 71013, Italy
Rome, Roma 00168, Italy
Como, 22100, Italy
Guadalajara, Jalisco 44650, Mexico
Mexico City, 11650, Mexico
Monterrey NL, 64623, Mexico
Rotterdam, South Holland 3045 PM, Netherlands
Lorenskog, Akershus 1478, Norway
San Juan, 00935, Puerto Rico
Ferrol, A Coruna 15405, Spain
Santiago de Compostela, A Coruna 15706, Spain
Jerez de la Frontera, Cadiz 11407, Spain
San Cristóbal de La Laguna, Santa Cruz De Tenerife 38320, Spain
Gothenburg, Västra Götaland County 413 45, Sweden
Warrington, Cheshire West And Chester WA5 1QG, United Kingdom
Darlington, County Durham DL3 6HX, United Kingdom
Hull, East Riding Of Yorkshire HU3 2JZ, United Kingdom
London, Greater London E1 2ES, United Kingdom
Southampton, Hampshire SO16 6YD, United Kingdom
Great Yarmouth, Norfolk NR31 6LA, United Kingdom
Kings Lynn, Norfolk PE30 4ET, United Kingdom
Kingston upon Thames, Surrey KT2 7QB, United Kingdom
Cambridge, CB2 0QQ, United Kingdom
Fontana, 92335, United Kingdom